US Patent Issued to Alexion Pharmaceuticals on July 8 for "Cerdulatinib for the treatment of b-cell malignancies" (California Inventors)

ALEXANDRIA, Va., July 9 -- United States Patent no. 12,350,269, issued on July 8, was assigned to Alexion Pharmaceuticals Inc. (Boston).

"Cerdulatinib for the treatment of b-cell malignancies" was invented by Anjali Pandey (Fremont, Calif.), Gregory Coffey (Emerald Hills, Calif.) and Janet Leeds (South San Francisco, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are compositions and methods for treating a relapsed or refractory hematologic cancer in a human patient in need thereof. The methods entail administering to the patient a daily dose of about 10 mg to about 75 mg of cerdulatinib or a pharmaceutically acceptable salt thereof, wherein the patients suffer one or more of a B-cell ...